Presynaptic kynurenate-sensitive receptors inhibit glutamate release

European Journal of Neuroscience

Volumn 13, Issue 11, 2001, Pages 2141-2147

  Carpenedo, R ^a   Pittaluga, A ^b   Cozzi, A ^a   Attucci, S ^a   Galli, A ^a   Raiteri, M ^b   Moroni, F ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Department of Experimental Medicine ^*  (Italy)

Author keywords

AMPA; Basal ganglia; Kainate; mGlu receptors; Microdialysis; Nicotinic ACh receptors; NMDA; Tryptophan and kynurenine metabolism

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR AGONIST; DEXTRO ASPARTIC ACID; GLUTAMIC ACID; GLYCINE; KAINIC ACID; KAINIC ACID RECEPTOR; KAINIC ACID RECEPTOR ANTAGONIST; KYNURENIC ACID; KYNURENINE 3 MONOOXYGENASE; METABOTROPIC RECEPTOR; METHYLLYCACONITINE; N METHYL DEXTRO ASPARTIC ACID; NICOTINIC RECEPTOR BLOCKING AGENT; PRESYNAPTIC RECEPTOR; TRITIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN MEMBRANE; CAUDATE NUCLEUS; CONTROLLED STUDY; CORPUS STRIATUM; DEPOLARIZATION; GENETIC TRANSFECTION; MALE; MICRODIALYSIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; SYNAPTOSOME;

ANIMALS; BRAIN; CAUDATE NUCLEUS; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR SPACE; GLUTAMIC ACID; KYNURENIC ACID; MALE; MICRODIALYSIS; PRESYNAPTIC TERMINALS; RATS; RATS, WISTAR; RECEPTORS, GLUTAMATE; RECEPTORS, NICOTINIC; SYNAPTIC TRANSMISSION; SYNAPTOSOMES; TRITIUM;

EID: 0034949090     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0953-816X.2001.01592.x     Document Type: Article

References (52)

1. Biochemical and behavioural studies on indole-pyruvic acid: A keto-analogue of tryptophan
2. Acetylcholine-mediated modulation of transmitter function
3. Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenic acid and have sedative and anticonvulsant activities
4. Regulation of neurotransmitter release by metabotropic glutamate receptors
5. Presynaptic kainate receptors in the monkey striatum
6. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus
7. Type 2 metabotropic glutamate receptors (mGluRs) tonically inhibit transmitter release in rat caudate nucleus: In vivo studies with (2S,1S,2S,3R) -2-(2-Carboxy-3-phenylcyclopropyl) glycine (PCCG-IV), a new potent and selective antagonist
8. Kynurenine hydroxylase inhibitors reduce ischemic brain damage: Studies with (m-nitrobenzoyl) - Alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl) thiazol-2yl]-benzensulfonamide (Ro 61-8048) in models of focal or global brain ischemia
9. Neuronal damage after the injection of aminooxyacetic acid into the rat entorhinal cortex: A silver impregnation study
10. Localization of kynurenine aminotransferase immunoreactivity in the rat hippocampus
11. Kynurenine pathway enzymes in a rat model of chronic epilepsy: Immunohistochemical study of activated glial cells
12. Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes
13. Nicotine-induced excitation of locus coeruleus neurons is blocked by elevated levels of endogenous kynurenic acid
14. Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors
15. 2+] but not in cAMP mediates the L-AP4 inhibition of glutamate release: PKC-mediated suppression of this inhibitory pathway
16. The brain metabolite kynurenic acid blocks α7 nicotinic acetylcholine receptors in rat hippocampal neurons in culture
17. 3H-ATPA: A high affinity ligand for GluR5 kainate receptors
18. 3H]-kainate binding
19. 3H-aspartate output in rat striatum
20. Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h-5-HT1D receptors
21. Protection against quinolinic-acid mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid
22. Tryptophan metabolism and brain function: Focus on kynurenine and other indole metabolites
23. 1 type receptors potentiate transmitter output in the rat cortex
24. Pharmacological characterization of 1-aminoindan-1,5-dicarboxylic acid (AIDA), a potent mGluR1 antagonist
25. Modulation of quinolinic and kynurenic acid content in the rat brain: Effects of endotoxins and nicotinylalanine
26. Presence of kynurenic acid in the mammalian brain
27. Thiocyanate stabilizes AMPA binding to quisqualate receptor
28. Neuroprotective effects of L-kynurenine on hypoxia-ischemia and NMDA lesions in neonatal rats
29. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal
30. Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis
31. Quinoxalines interact with the glycine recognition site of NMDA receptors: Studies in guinea-pig myenteric plexus and in rat cortical membranes
32. Synthesis and pharmacological characterization of all sixteen stereoisomers of 2-(-2′-carboxy-3′-phenylcyclopropyl) glycine. Focus on (2S, 1′S, 2′S, 3′R) -2′-carboxy-3′-phenylcyclopropyl) glycine, a novel and selective group 2 metabotropic glutamate receptor antagonist
33. Dopaminergic control of kynurenate levels and NMDA toxicity in the developing rat striatum
34. A simple apparatus for studying the release of neurotransmitters from synaptosomes
35. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
36. Nicotinylalanine increases the formation of kynurenic acid in the brain and antagonizes convulsions
37. Presynaptic receptors and the control of glutamate exocytosis
38. Presynaptic kainate receptor mediation of frequency facilitation at hippocampal mossy fiber synapses
39. Modulation and function of kynurenic acid in the immature rat brain
40. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo (F) quinoxaline: A neuroprotectant for cerebral ischemia
41. (R,S) -3,4-dichlorobenzoylalanine (FCE 28833A) causes a large and persistent increase in brain kynurenic acid levels in rats
42. Neuropharmacology of quinolinic and kynurenic acids
43. Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection
44. Cerebral synthesis and release of kynurenic acid: An endogenous antagonist of excitatory amino acid receptors
45. L-2-Amino-4-phosphonobutyrate (L-AP4) is an agonist at the type-IV metabotropic glutamate receptor which is negatively coupled to adenylate cyclase
46. A pharmacological characterization of the mGluR1a subtype of the metabotropic glutamate receptor expressed in baby hamster kidney cell line
47. Identification and quantification of kynurenic acid in human brain tissue
48. Measurement of transmitter release by intracranial dialysis
49. Neuroprotective potency of kynurenic acid against excitotoxicity
50. Kynurenine and probenecid inhibit pentylenetetrazol and NMDA-induced seizures and increase kynurenic acid concentrations in the brain
51. Modulation of ACh and GABA turnover in the striatum by the glutamatergic cortico-striatal pathway
52. Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo